Queens Hospital Center (QHC), also known as NYC Health + Hospitals/Queens and originally called Queens General Hospital, is a large public hospital campus in the Jamaica Hills and Hillcrest neighborhoods of Queens in New York City. It is operated by NYC Health + Hospitals, a public benefit corporation of the city.Queens General Hospital opened in 1935 as the first municipal general hospital in the borough. It would absorb the adjacent Queensboro Hospital for Communicable Diseases shortly after opening, and the campus would later include Triboro Hospital for Tuberculosis, which opened in 1941. Queens Hospital Center was formed in 1952 and 1959 with the official merger of the three hospitals along with two other Queens medical facilities. The current campus consists of modern buildings constructed in the 21st century, along with the former Triboro Hospital building.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist widely prescribed for type 2 diabetes mellitus and obesity, is generally well tolerated but can be associated with gastrointestinal adverse effects and, rarely, pancreatitis. As its use grows, clinicians must remain aware of potential complications, particularly in patients with additional risk factors. We report the case of a 57-year-old woman with diabetes, hypertension, and hyperlipidemia who presented with acute severe epigastric pain and persistent vomiting shortly after consuming a large, fatty meal. She had been receiving semaglutide for several months. Laboratory studies showed marked leukocytosis, hyperglycemia with an anion gap metabolic acidosis, and a lipase level exceeding 3000 U/L. CT imaging demonstrated acute interstitial edematous pancreatitis with peripancreatic fluid and early concern for necrosis. She was treated conservatively with aggressive intravenous hydration, bowel rest, electrolyte repletion, and analgesia. Her condition improved with supportive care, and she was discharged with close outpatient follow-up. This case highlights the importance of recognizing pancreatitis as a possible multifactorial complication in patients using GLP-1 receptor agonists. This case highlights the need for clinicians to maintain awareness of pancreatitis as a potential adverse effect in patients receiving semaglutide, especially those with additional risk factors such as biliary pathology or dietary triggers. As the use of GLP-1 receptor agonists continues to grow, careful assessment of abdominal symptoms and early recognition of pancreatic inflammation are essential for optimizing outcomes and guiding safe prescribing practices.
Preoperative anxiety is a common problem in pediatric surgical patients and is a recognized predictor of emergence delirium (ED) and postoperative negative behavioral changes (PNBC). Intranasal premedication has emerged as a preferred route in children. Both dexmedetomidine and esketamine have demonstrated independent efficacy in this context. Their pharmacological complementarity has prompted growing interest in their combined use, yet no systematic review has comprehensively compared their efficacy and safety as monotherapies across pediatric procedural settings. This review aimed to evaluate and compare intranasal dexmedetomidine versus intranasal esketamine in pediatric patients. The study was conducted in accordance with the Cochrane Handbook and reported following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Five electronic databases were searched without date restriction. Risk of bias was assessed using the Cochrane RoB 2 tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for the cohort study. Pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals were calculated using RevMan 5.4, with fixed- or random-effects models applied based on heterogeneity. The final analysis included five studies (four RCTs, one prospective cohort) with a combined sample of 481 pediatric participants. In elective surgical settings, dexmedetomidine at 2 µg/kg significantly reduced ED incidence compared to esketamine (RR 0.57 (0.38, 0.86); p=0.008) and was associated with significantly lower Pediatric Anesthesia Emergence Delirium (PAED) scale scores (MD -1.28 (-2.36, -0.20); p=0.02). Conversely, esketamine demonstrated significantly lower PAED scores in the bronchoscopy subgroup (MD 2.73 (1.84, 3.62); p<0.00001). Dexmedetomidine was also associated with significantly lower Face Legs Activity Cry Consolability (FLACC) pain scores in the emergency department subgroup (MD -3.25 (-5.64, -0.86); p=0.008). Regarding the primary endpoints, the overall pooled ED incidence did not differ significantly between agents (RR 0.77 (0.37, 1.62); p=0.49), nor did overall FLACC pain scores (MD -0.24 (-1.13, 0.65); p=0.60). Intranasal dexmedetomidine and esketamine demonstrate comparable overall efficacy and safety as pediatric premedication agents, with neither showing a significant pooled advantage over the other. However, their comparative performance is context- and dose-dependent, with dexmedetomidine at 2 µg/kg proving superior in elective surgical settings, and esketamine performing better in bronchoscopy procedures. These findings support individualized agent selection based on procedural context and dosing rather than a universal preference for either agent. Larger, standardized multicenter trials are needed to establish definitive evidence-based premedication recommendations across pediatric surgical settings.
Kaposi sarcoma (KS) is an HHV-8-mediated vascular malignancy encompassing four distinct clinical variants: classic, endemic, iatrogenic, and AIDS-associated. While classically indolent, KS can pursue an aggressive course in the context of HIV infection. Pleural involvement, particularly chylous effusion, represents a rare but grave manifestation of the disease. In cases of chylous effusion, pleural fluid analysis typically reveals a triglyceride concentration >110 mg/dL or the presence of chylomicrons, findings that signify true chylous involvement. We report the case of a 33-year-old man with AIDS-associated KS complicated by chylous pleural effusion. The patient was initiated on antiretroviral therapy and received a single dose of chemotherapy, after which he developed biochemical evidence of tumor lysis syndrome 16 days later, leading to fatal clinical deterioration. This case underscores the catastrophic potential of KS complicated by chylous pleural effusion and highlights the importance of vigilance for life-threatening complications during therapy.
Autism Spectrum Disorder (ASD) and Attention Deficit and Hyperactivity Disorder (ADHD) are two psychiatric disorders frequently encountered in children. ADHD is further categorized into three subtypes. The diagnostic processes for these conditions are complex and often prone to misclassification. We proposed a lightweight deep neural network, ADBrainNet, to differentiate ASD, ADHD combined, ADHD hyperactive/impulsive, ADHD inattentive and neurotypical individuals. Our methodology was benchmarked against prevalent ImageNet transfer learning methods, including AlexNet, MobileNet, ResNet18, and Xception, for training on resting-state fMRI images sourced from ABIDE and ADHD-200 datasets. ADBrainNet achieved superior performance on the independent external testing set through five-fold cross-validation, with a mean (± standard deviation) accuracy, precision, recall, and F1 score of 61.87
We present the case of a 26-year-old female patient with a history of asthma who initially presented with symptoms suggestive of a common infection. Her constellation of facial swelling, productive cough, and fatigue, coupled with imaging findings, first led to a diagnosis of right upper lobe pneumonia and suspected cellulitis. Despite appropriate antibiotic therapy, her symptoms persisted, and her clinical picture became more complex with the identification of Actinomyces in her sputum, shifting the differential diagnosis toward a more indolent cervicofacial infection. However, a progressively worsening and profound leukocytosis, along with a lack of clinical improvement, prompted further investigation. This ultimately revealed a large mediastinal mass, and subsequent tissue analysis confirmed a diagnosis of primary mediastinal large B-cell lymphoma. This case highlights a critical diagnostic challenge, illustrating how a rare and aggressive malignancy can masquerade as a common infectious process in a young, otherwise healthy individual, leading to a significant delay in diagnosis and treatment.